Literature DB >> 15723255

Three-dimensional trabecular bone architecture of the lumbar spine in bone metastasis from prostate cancer: comparison with degenerative sclerosis.

Tsutomu Tamada1, Teruki Sone, Yoshimasa Jo, Shigeki Imai, Yasumasa Kajihara, Masao Fukunaga.   

Abstract

OBJECTIVE: Prostate cancer frequently metastasizes to bone, inducing osteosclerotic lesions. The objective of this study was to clarify the three-dimensional (3D) trabecular bone microstructure in bone metastasis from prostate cancer by comparison with normal and degenerative sclerotic bone lesions, using microcomputed tomography (micro-CT). DESIGN AND MATERIALS: A total of 32 cancellous bone samples were excised from the lumbar spine of six autopsy patients: 15 metastatic samples (one patient), eight degenerative sclerotic samples (four patients) and the rest from normal sites (three patients). The samples were serially scanned cross-sectionally by micro-CT with a pixel size of 23.20 microm, slice thickness of 18.56 microm, and image matrix of 512 x 512. Each image data set consisted of 250 consecutive slices. The volumes of interest (96 x 96 x 120 voxels) were defined in the original image sets and 3D indices of the trabecular microstructure were determined.
RESULTS: The trabecular thickness (Tb.Th) in degenerative sclerotic lesions was significantly higher than that in normal sites, whereas no significant difference was observed in trabecular number (Tb.N). By contrast, in metastatic lesions, the Tb.N was significantly higher with increased bone volume fraction (BV/TV) than in normal sites, and no significant difference was found in Tb.Th. The characteristics of the trabecular surface in the metastatic samples showed concave structural elements with an increase in BV/TV, indicating osteolysis of the trabecular bone. In 3D reconstructed images, increased trabecular bone with an irregular surface was observed in samples from metastatic sites, which were uniformly sclerotic on soft X-ray radiographs.
CONCLUSION: These results support, through 3D morphological features, the strong bone resorption effect in bone metastasis from prostate cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15723255     DOI: 10.1007/s00256-004-0855-x

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  27 in total

1.  Trabecular bone pattern factor--a new parameter for simple quantification of bone microarchitecture.

Authors:  M Hahn; M Vogel; M Pompesius-Kempa; G Delling
Journal:  Bone       Date:  1992       Impact factor: 4.398

2.  Morphometric evidence for bone resorption and replacement in prostate cancer.

Authors:  N W Clarke; J McClure; N J George
Journal:  Br J Urol       Date:  1991-07

Review 3.  Bone metastases: improving the therapeutic index.

Authors:  H I Scher; L W Chung
Journal:  Semin Oncol       Date:  1994-10       Impact factor: 4.929

4.  Generalised increase in bone resorption in carcinoma of the prostate.

Authors:  G H Urwin; R C Percival; S Harris; M N Beneton; J L Williams; J A Kanis
Journal:  Br J Urol       Date:  1985-12

5.  Urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer.

Authors:  S Takeuchi; K Arai; H Saitoh; K Yoshida; M Miura
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

6.  Bone metabolic markers in bone metastases.

Authors:  M Koizumi; Y Yamada; T Takiguchi; E Nomura; M Furukawa; T Kitahara; T Yamashita; H Maeda; S Takahashi; K Aiba
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 7.  Bisphosphonates in prostate carcinoma.

Authors:  S Adami
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

Review 8.  Osteoblastic metastasis in advanced prostate cancer.

Authors:  M Koutsilieris
Journal:  Anticancer Res       Date:  1993 Mar-Apr       Impact factor: 2.480

9.  Dissociation of bone formation markers in bone metastasis of prostate cancer.

Authors:  M Koizumi; H Maeda; K Yoshimura; T Yamauchi; T Kawai; E Ogata
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Metabolic effects of pamidronate in patients with metastatic bone disease.

Authors:  J Vinholes; C Y Guo; O P Purohit; R Eastell; R E Coleman
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

View more
  10 in total

1.  Influence of Metastatic Bone Lesion Type and Tumor Origin on Human Vertebral Bone Architecture, Matrix Quality, and Mechanical Properties.

Authors:  Stacyann Bailey; Marc A Stadelmann; Philippe K Zysset; Deepak Vashishth; Ron N Alkalay
Journal:  J Bone Miner Res       Date:  2022-04-05       Impact factor: 6.390

2.  Frequency and imaging features of the adjacent osseous changes of salivary gland carcinomas in the head and neck region.

Authors:  Daisuke Horiuchi; Taro Shimono; Hiroyuki Tatekawa; Taro Tsukamoto; Hirotaka Takita; Masahiro Okazaki; Yukio Miki
Journal:  Neuroradiology       Date:  2022-05-07       Impact factor: 2.995

3.  Micro computed tomography for vascular exploration.

Authors:  Lyubomir Zagorchev; Pierre Oses; Zhen W Zhuang; Karen Moodie; Mary Jo Mulligan-Kehoe; Michael Simons; Thierry Couffinhal
Journal:  J Angiogenes Res       Date:  2010-03-05

4.  Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice--a quantitative study using microCT and Raman spectroscopy.

Authors:  Xiaohong Bi; Julie A Sterling; Alyssa R Merkel; Daniel S Perrien; Jeffry S Nyman; Anita Mahadevan-Jansen
Journal:  Bone       Date:  2013-07-15       Impact factor: 4.398

Review 5.  The effects of metastatic lesion on the structural determinants of bone: Current clinical and experimental approaches.

Authors:  Stacyann Bailey; David Hackney; Deepak Vashishth; Ron N Alkalay
Journal:  Bone       Date:  2019-11-21       Impact factor: 4.398

6.  Improved estimates of strength and stiffness in pathologic vertebrae with bone metastases using CT-derived bone density compared with radiographic bone lesion quality classification.

Authors:  Ron N Alkalay; Michael W Groff; Marc A Stadelmann; Florian M Buck; Sven Hoppe; Nicolas Theumann; Umesh Mektar; Roger B Davis; David B Hackney
Journal:  J Neurosurg Spine       Date:  2021-09-03

7.  Conventional finite element models estimate the strength of metastatic human vertebrae despite alterations of the bone's tissue and structure.

Authors:  Marc A Stadelmann; Denis E Schenk; Ghislain Maquer; Christopher Lenherr; Florian M Buck; Dieter D Bosshardt; Sven Hoppe; Nicolas Theumann; Ron N Alkalay; Philippe K Zysset
Journal:  Bone       Date:  2020-08-20       Impact factor: 4.626

8.  Comparison of Vascular Morphometry in Jawbones and Long Bones: Micro-CT Study in a Rat Model Treated with Zoledronic Acid.

Authors:  Jing Yi Wang; Ru Qing Yu; Lei Huo; Nian Jing Rao; Weijia William Lu; Li Wu Zheng
Journal:  Biomed Res Int       Date:  2021-05-12       Impact factor: 3.411

9.  Differentiation of osteosarcoma from osteomyelitis using microarchitectural analysis on panoramic radiographs.

Authors:  Ji-Hun Jung; Kyung-Hoe Huh; Tae-Hoon Yong; Ju-Hee Kang; Jo-Eun Kim; Won-Jin Yi; Min-Suk Heo; Sam-Sun Lee
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

10.  Evaluation of Load-To-Strength Ratios in Metastatic Vertebrae and Comparison With Age- and Sex-Matched Healthy Individuals.

Authors:  Dennis E Anderson; Michael W Groff; Thomas F Flood; Brett T Allaire; Roger B Davis; Marc A Stadelmann; Philippe K Zysset; Ron N Alkalay
Journal:  Front Bioeng Biotechnol       Date:  2022-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.